Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Catalent has signed an agreement with ViralClear to work on the development of a potential treatment for adults with advanced COVID-19.
read more
Symbiosis has signed a supply agreement with AstraZeneca for sterile manufacture of the COVID-19 recombinant adenovirus vaccine known as AZD1222.
read more
AGU Planungsgesellschaft mbH and TetraScience have announced a new partnership to integrate their flagship products to automatically collect and unify R&D data in life sciences.
read more
Avacta has announce the first Affimer-based rapid test strips to detect SARS-COV-2 spike protein have been developed and evaluated by Avacta’s partners at Cytiva and show positive initial performance data.
read more
Stevanato Group and CEPI have signed an agreement for the supply of 100 million Type 1 Borosilicate glass vials for a vaccine against COVID-19 virus, should product(s) be proven safe and effective.
read more
Artelo Biosciences has expanded its existing research and worldwide commercial license agreement with The Research Foundation For The State University of New York, Stony Brook.
read more
Catalent announced the completion of a $3.2 million expansion program at its consumer health manufacturing facilities in Strathroy, Canada and Sorocaba, Brazil.
read more
Edinburgh-based Ingenza has increased its footprint to over 12,000 sq ft within the Roslin Innovation Centre.
read more
Piramal and The Carlyle Group announced CA Clover Intermediate II Investments has agreed to invest fresh equity capital for a 20% stake in Piramal Pharma that will contain its pharmaceutical businesses.
read more
Grand River Aseptic Manufacturing (GRAM) completed its major $60 million expansion project and recently took occupancy.
read more
Symbiosis Pharmaceutical Services has secured £1million of finance from Allied Irish Bank (GB) to support its 2020 growth strategy.
read more
Cambrex announced it is investing $3.6 million at its Karlskoga, Sweden facility to increase flexible drug substance manufacturing capacity.
read more
Freyr has announced the launch of a web platform for Covid-19 driven with real-time information for manufacturers.
read more
Vetter and Rentschler Biopharma have announced their strategic collaboration, to enhance their services and offer complementary skills and experience along the biopharmaceutical value chain.
read more
Eremid Research Services has been established as the new name for the commercial arm of the 501(c)(3) non-profit, research organization - DHMRI.
read more